% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • peaksisland Mar 24, 2013 9:12 PM Flag

    ----------- Abstral is just a re-formulation of fentany ----------

    However, owing to generic availability and physician familiarity, older opioids such as immediate-release morphine will continue to dominate breakthrough cancer pain treatment.

    “We anticipate that fast acting fentanyl reformulations will enjoy significant uptake in the breakthrough pain market segment,” said Decision Resources Analyst Janie Mackay, Ph.D. “However, experts we interviewed indicate that physicians treating cancer pain are often reluctant to prescribe novel therapies because of strict adherence to the World Health Organization pain ladder which advocates the use of older analgesics such as morphine.....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.7477+0.0177(+1.02%)12:17 PMEDT